This is a community-generated profile. If you would like to claim it, please .
Epizyme Funding
$61.5M
55 rounds
Epizyme is active in the following markets / industries: biotechnology and health and wellness. The company has secured funding across 5 rounds, totaling in an amount of $61.5M. Their most recent funding was raised on February 12, 2014.
Funding Rounds
U
$10000000UnknownFeb 2014
U
$4000000UnknownOct 2011
U
$7500000B
$8000000Series BDec 2009
B
$32000000Series BOct 2009
+1
Investors of Epizyme
Otis Handy
Seeking role in Customer Success, HR, Operations. Open to most industries especially Tech, Media, Legal and Finance. Focused on culture and responsibilities.
Amgen Ventures
Leukemia & Lymphoma Society
GSK (GlaxoSmithKline)
Dylan Bird
Former VP of Bus Dev at GenturaDx. Part of founding executive team, built company from 3 to 70 employees, raised $40M+, led the succesful sale of the company
Glaxosmithkline
Develops/manufactures pharmaceuticals, vaccines, & healthcare products
Rounds
U
Amgen
Rounds
B
Bay City Capital
Rounds
B